Should we consider TTVR in patients with straightforward anatomy who are eligible for T-TEER?

PCR Perspectives

Summary

Lukas Stolz and Rebecca Hahn discuss advances in transcatheter tricuspid valve intervention, emphasising that reducing tricuspid regurgitation (TR) to mild levels is key for improving patient outcomes, including mortality and heart failure hospitalisations. Decision-making between transcatheter edge-to-edge repair (T-TEER) and transcatheter tricuspid valve replacement (TTVR) depends on anatomy, imaging, and patient factors like pacemakers or bleeding risk.

This interview was filmed at PCR London Valves 2025: see more videos here.